ADMA Biologics Inc

ADMA Biologics Inc. is a privately held company based in Ramsey, New Jersey. With a workforce of 303 employees, the company generates an annual revenue of $500 million. ADMA Biologics specializes in the development, manufacturing, and marketing of plasma-derived biologics. The company focuses on producing specialty medications for patients with immunodeficiencies and those at risk for specific infectious diseases. ADMA Biologics offers three FDA-approved products: BIVIGAM® for primary humoral immunodeficiency (PI), ASCENIV™ also for PI, and NABI-HB® for enhanced immunity against the hepatitis B virus. These products are manufactured at their FDA-licensed facility in Boca Raton, Florida. ADMA Biologics distinguishes itself through its vertically integrated approach, encompassing both plasma collection through its subsidiary, ADMA BioCenters, and the manufacturing of its proprietary products. This ensures a consistent and reliable supply chain for its specialized medications. Additionally, the company holds multiple patents related to its products and product candidates, highlighting its commitment to innovation. For inquiries, visit ADMA Biologics' website at www.admabiologics.com.